Fatigue Is a Frequent and Clinically Relevant Problem in Ehlers-Danlos Syndrome

Seminars in Arthritis and Rheumatism

Volumn 40, Issue 3, 2010, Pages 267-274

  Voermans, Nicol C ^a   Knoop, Hans ^a   van de Kamp, Nicole ^a   Hamel, Ben C ^a   Bleijenberg, Gijs ^a   van Engelen, Baziel G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Concentration; Ehlers Danlos syndrome; Fatigue; Fatigue severity; Heritable connective tissue disorder; Pain; Questionnaire; Self efficacy; Sleep disturbances; Social functioning

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CODEINE; OPIATE; OPIATE AGONIST; TRAMADOL;

ADOLESCENT; ADULT; AGED; ARTICLE; COMORBIDITY; CONCENTRATION LOSS; CROSS-SECTIONAL STUDY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DISLOCATION; DISTRESS SYNDROME; DRUG USE; EHLERS DANLOS SYNDROME; FATIGUE; FEMALE; FUNCTIONAL DISEASE; HUMAN; JOINT HYPERMOBILITY; MAJOR CLINICAL STUDY; MALE; MUSCLE HYPOTONIA; MUSCLE WEAKNESS; MUSCULOSKELETAL PAIN; PAIN ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSYCHOSOCIAL DISORDER; QUESTIONNAIRE; SEDATION; SELF CONCEPT; SIDE EFFECT; SKIN BRUISING; SLEEP DISORDER; SOCIAL SUPPORT;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; EHLERS-DANLOS SYNDROME; FATIGUE; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PAIN; PREVALENCE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 78649443435     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2009.08.003     Document Type: Article

References (33)

1. Beighton P., De Paepe A., Steinmann B., Tsipouras P., Wenstrup R.J. Ehlers-Danlos syndromes: revised nosology. Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 1998, 77:31-37.
2. Schalkwijk J., Zweers M.C., Steijlen P.M., Dean W.B., Taylor G., van Vlijmen I., et al. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N Engl J Med 2001, 345:1167-1175.
3. Burch G.H., Gong Y., Liu W., Dettman R.W., Curry C.J., Smith L., et al. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet 1997, 17:104-108.
4. Steinmann B., Royce P.M., Superti-Furga A. The Ehlers-Danlos syndromes. Connective Tissue and Its Heritable Disorders 2002, 431-523. Wiley-Liss Inc, Wilmington (DE). B. Steinmann, P.M. Royce (Eds.).
5. Gawthrop F., Mould R., Sperritt A., Neale F. Ehlers-Danlos syndrome. BMJ 2007, 335:448-450.
6. Vercoulen J.H., Swanink C.M., Fennis J.F., Galama J.M., van der Meer J.W., Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994, 38:383-392.
7. Kalkman J.S., Schillings M.L., van der Werf S.P., Padberg G.W., Zwarts M.J., van Engelen B.G., et al. Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I. J Neurol Neurosurg Psychiatry 2005, 76:1406-1409.
8. Schwid S.R., Covington M., Segal B.M., Goodman A.D. Fatigue in multiple sclerosis: current understanding and future directions. J Rehabil Res Dev 2002, 39:211-224.
9. Friedman J., Friedman H. Fatigue in Parkinson's disease. Neurology 1993, 43:2016-2018.
10. van der Werf S.P., van den Broek H.L., Anten H.W., Bleijenberg G. Experience of severe fatigue long after stroke and its relation to depressive symptoms and disease characteristics. Eur Neurol 2001, 45:28-33.
11. Repping-Wuts H., Fransen J., van Achterberg T., Bleijenberg G., van Riel P. Persistent severe fatigue in patients with rheumatoid arthritis. J Clin Nurs 2007, 16:377-383.
12. Servaes P., Verhagen C.A., Bleijenberg G. Relations between fatigue, neuropsychological functioning, and physical activity after treatment for breast carcinoma: daily self-report and objective behavior. Cancer 2002, 95:2017-2026.
13. Kalkman J.S., Schillings M.L., Zwarts M.J., van Engelen B.G., Bleijenberg G. The development of a model of fatigue in neuromuscular disorders: a longitudinal study. J Psychosom Res 2007, 62:571-579.
14. Voermans N.C., van Alfen N., Pillen S., Lammens M., Schalkwijk J., Zwarts M.J., et al. Neuromuscular involvement in various types of Ehlers-Danlos syndrome. Ann Neurol 2009, 65:687-697.
15. Scheeres K., Wensing M., Bleijenberg G., Severens J.L. Implementing cognitive behavior therapy for chronic fatigue syndrome in mental health care: a costs and outcomes analysis. BMC Health Serv Res 2008, 8:175.
16. Vercoulen J.H., Hommes O.R., Swanink C.M., Jongen P.J., Fennis J.F., Galama J.M., et al. The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch Neurol 1996, 53:642-649.
17. Berger F., Brahler E., Kunkel R., Stephanos S. [Verbal behavior and communication experience of psychosomatic patients in the first psychoanalytic interview in connection with the concept of "pensee operatoire"]. Z Psychosom Med Psychoanal 1981, 27:45-58.
18. Jacobs H.M., Luttik A., Touw-Otten F.W., de Melker R.A. [The sickness impact profile; results of an evaluation study of the Dutch version]. Ned Tijdschr Geneeskd 1990, 134:1950-1954.
19. Pfeiffer G., Wicklein E.M., Ratusinski T., Schmitt L., Kunze K. Disability and quality of life in Charcot-Marie-Tooth disease type 1. J Neurol Neurosurg Psychiatry 2001, 70:548-550.
20. Ware J.E., Snow K.K., Kosinski M. SF-36 Health Survey manual and interpretation guide 2008, New England Medical Center, The Health Institute, Boston (MA).
21. Stewart J.W., Quitkin F.M., McGrath P.J., Rabkin J.G., Markowitz J.S., Tricamo E., et al. Social functioning in chronic depression: effect of 6 weeks of antidepressant treatment. Psychiatry Res 1988, 25:213-222.
22. Beck A.T., Guth D., Steer R.A., Ball R. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther 1997, 35:785-791.
23. Arrindell W.A., Ettema J.H.M. SCL-90-R: Handleiding bij een multidimensionele psychopathologie-indicator 1-1-1986, Lisse, Swets & Zeitlinger.
24. Prins J.B., Bleijenberg G., Bazelmans E., Elving L.D., de Boo T.M., Severens J.L., et al. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet 2001, 357:841-847.
25. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975, 1:277-299.
26. Vercoulen J.H., Alberts M., Bleijenberg G. De Checklist Individual Strength (CIS). Gedragstherapie [behaviour therapy] 1999, 32:131-136.
27. Sacheti A., Szemere J., Bernstein B., Tafas T., Schechter N., Tsipouras P. Chronic pain is a manifestation of the Ehlers-Danlos syndrome. J Pain Symptom Manage 1997, 14:88-93.
28. Naughton F., Ashworth P., Skevington S.M. Does sleep quality predict pain-related disability in chronic pain patients?. The mediating roles of depression and pain severity. Pain 2007, 127:243-252.
29. Verbraecken J., Declerck A., van de Heyning P., de Backer W., Wouters E.F. Evaluation for sleep apnea in patients with Ehlers-Danlos syndrome and Marfan: a questionnaire study. Clin Genet 2001, 60:360-365.
30. Prins J.B., Bos E., Huibers M.J., Servaes P., van der Werf S.P., van der Meer J.W., et al. Social support and the persistence of complaints in chronic fatigue syndrome. Psychother Psychosom 2004, 73:174-182.
31. Prins J.B., van der Meer J.W., Bleijenberg G. Chronic fatigue syndrome. Lancet 2006, 367:346-355.
32. Gielissen M.F., Verhagen S., Witjes F., Bleijenberg G. Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial. J Clin Oncol 2006, 24:4882-4887.
33. Milne H.M., Wallman K.E., Gordon S., Courneya K.S. Effects of a combined aerobic and resistance exercise program in breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat 2008, 108:279-288.